United States· US:42571-381_fa3753a6-a410-6ae8-e053-6394a90a0106
CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE
A medicinal product containing chlordiazepoxide hydrochloride; clidinium bromide, registered in United States by Micro Labs Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- Manufacturer
- Micro Labs Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc114257138101100 CAPSULE in 1 BOTTLE (42571-381-01)
- ndc1142571-381-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlordiazepoxide hydrochloride; clidinium bromide in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaLIBRAXBAUSCH HEALTH, CANADA INC.
- FranceLIBRAX, comprimé enrobéVIATRIS MEDICAL
- NorwayLibraxBausch Health
- FinlandLibraxViatris Oy
- United KingdomLibrax capsulesImported (United States)
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Cyprus · Bralix, Librax
- Finland · Librax
- France · Librax
- Greece · Librax
- Iceland · Librax
- Portugal · Librax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9aaa5401-2524-4e70-807a-30eb9233ed2b GET /v1/drugs/9aaa5401-2524-4e70-807a-30eb9233ed2b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5; 2.5",
"substance": "CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE",
"productndc": "42571-381",
"dosage_form": "CAPSULE",
"dea_schedule": "CIV",
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA215835",
"marketing_category": "ANDA"
}See everything about chlordiazepoxide hydrochloride; clidinium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.